Skandinaviska Enskilda Banken Ab (Publ) 4 D Molecular Therapeutics, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.5 Billion
- Q3 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 44,600 shares of FDMT stock, worth $207,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,600
Previous 44,600
-0.0%
Holding current value
$207,390
Previous $936,000
48.5%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding FDMT
# of Institutions
147Shares Held
56.8MCall Options Held
137KPut Options Held
111K-
Bvf Inc San Francisco, CA7.38MShares$34.3 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$23.7 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$22.8 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$20.5 Million4.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$19 Million1.63% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $151M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...